Fengqi Q. Fang

193 United Road
Dalian, 116021, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

HFA-ICOS score in predicting cancer therapy-related cardiac dysfunction among breast cancer and lymphoma patients

HFA-ICOS score in predicting cancer therapy-related cardiac dysfunction among breast cancer and lymphoma patients

Journal: Zhonghua xin xue guan bing za zhi

Published: August 18, 2025

Interpretable machine learning for urothelial cells classification and risk scoring in urine cytology.

Interpretable machine learning for urothelial cells classification and risk scoring in urine cytology.

Journal: iScience

Published: July 13, 2025

An Artificial Intelligence-Based Method for Risk Stratification of Urothelial Carcinoma from Liquid-Based Urine Cytology Whole-Slide Images.

An Artificial Intelligence-Based Method for Risk Stratification of Urothelial Carcinoma from Liquid-Based Urine Cytology Whole-Slide Images.

Journal: Acta cytologica

Published: June 24, 2025

Personalized Trastuzumab-Induced Cardiac Dysfunction Risk Stratification and Surveillance.

Personalized Trastuzumab-Induced Cardiac Dysfunction Risk Stratification and Surveillance.

Journal: JACC. CardioOncology

Published: January 07, 2025

Pyrotinib and Nab-Paclitaxel in HER2-Positive Breast Cancer (PANHER Trial): A Prospective, Single-Arm, Phase II Trial.

Pyrotinib and Nab-Paclitaxel in HER2-Positive Breast Cancer (PANHER Trial): A Prospective, Single-Arm, Phase II Trial.

Journal: Cancer science

Published: November 21, 2024

Corrigendum: The value of second-line anti-HER2 therapy in metastatic HER-2 positive patients: a cost-effectiveness analysis in China.

Corrigendum: The value of second-line anti-HER2 therapy in metastatic HER-2 positive patients: a cost-effectiveness analysis in China.

Journal: Frontiers in pharmacology

Published: October 30, 2024

Establishment of Prognostic Nomogram for Male Breast Cancer Patients: A Surveillance, Epidemiology and End Results Database Analysis.

Establishment of Prognostic Nomogram for Male Breast Cancer Patients: A Surveillance, Epidemiology and End Results Database Analysis.

Journal: Cancer control : journal of the Moffitt Cancer Center

Published: August 08, 2024

Exploration and practice of cardio-oncology

Exploration and practice of cardio-oncology

Journal: Zhonghua yi xue za zhi

Published: April 21, 2024

The value of second-line anti-HER2 therapy in metastatic HER-2 positive patients: a cost-effectiveness analysis in China.

The value of second-line anti-HER2 therapy in metastatic HER-2 positive patients: a cost-effectiveness analysis in China.

Journal: Frontiers in pharmacology

Published: February 05, 2024

Retraction notice to "Long noncoding RNA TP73-AS1 promotes non-small cell lung cancer progression by competitively sponging miR-449a/EZH2" [Biomed. Pharmacother. 104 (2018) 705-711].

Retraction notice to "Long noncoding RNA TP73-AS1 promotes non-small cell lung cancer progression by competitively sponging miR-449a/EZH2" [Biomed. Pharmacother. 104 (2018) 705-711].

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: October 06, 2023

Disitamab Vedotin (RC48) for HER2-positive advanced breast cancer: a case report and literature review.

Disitamab Vedotin (RC48) for HER2-positive advanced breast cancer: a case report and literature review.

Journal: Frontiers in oncology

Published: August 31, 2023

Endocrine therapy of short duration prevents local and contralateral recurrence of ductal carcinoma in situ of the breast: A multicenter retrospective cohort study in China.

Endocrine therapy of short duration prevents local and contralateral recurrence of ductal carcinoma in situ of the breast: A multicenter retrospective cohort study in China.

Journal: Chinese medical journal

Published: July 08, 2023

Showing 1-12 of 25

Last Updated: 09/26/2026